Overview

Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers

Status:
Completed
Trial end date:
2013-01-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the pharmacokinetics of CKD-11101 and NESP after SC administration in health male volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Collaborator:
Seoul National University Hospital
Treatments:
Darbepoetin alfa